Administration of buprenorphine depot injection by WA pharmacists - PDL Australia

Member support:

Disclaimer: This article was published in 2023 and reflects the information available at that time.

On 13 September 2023, the WA Government released a new Structured Administration and Supply Arrangement (SASA) that authorises a registered pharmacist trained in the Community Program for Opioid Pharmacotherapy (CPOP) to administer depot buprenorphine when requested by the patient and p…

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article

Previous

Checking SafeScript when supplying pregabalin, gabapentin and tramadol

20 September 2023

Next

NSW/ACT Pharmacy Trial – extended supply of oral contraceptive pills by community pharmacists

10 October 2023

Related Practice Alerts

Cover for partnered charting and prescribing activities

24 November 2025

Is this the right jab? A vaccination service reminder

20 November 2025

2024-2025 most reported medicines